European regulators have started a review of Amgen’s drug Tavneos following “emerging information that raises questions ...
Three U.S. senators sent a letter to the HHS Office of Inspector General raising questions about TrumpRx — whose structure ...
As more consumers order up lab tests and genetic screenings, experts say it could impact insurance, loans, and employment decisions.
First-year biomedical graduate students across the country said labs have been hesitant to take them in due to a tenuous ...
The lawsuit’s outcome could have major implications for millions of Americans, especially after Congress voted in 2025 to ...
California Gov. Gavin Newsom announced his office was filing a civil rights complaint with HHS accusing CMS Administrator Mehmet Oz of discrimination.
The proposal would mark a significant change for the secretive PBM industry, which often shields crucial data from its clients.
The report claims “there is no evidence of benefit” from gender-affirming care for minors, while ignoring the many studies that show consistent short- and medium-term benefits. The report concludes ...
To be clear, there are laudable ideas, from a public health perspective, in the new guidelines. There is good reason to believe that ultra-processed foods (although difficult to define) are linked ...
Sanofi and Roche reported fourth-quarter and full-year 2025 earnings. Summit Therapeutics said the FDA accepted its application seeking approval of its PD-1/VEGF antibody ivonescimab to treat ...
The White House unveiled a new effort to streamline the country’s response to its drug and alcohol epidemic. But the ...
Ten technology vendors are offering $600 million worth of discounts to states that pick them to help implement Medicaid work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results